Uterine fibroid disease is a very common problem among women of reproductive age. Until recently, the only treatment for fibroids was surgery. Today, owing to the developments in medicine, there are several nonsurgical treatment options. Among them, fibroid embolization is the mostly accepted one and has been in clinical practice for more than 15 years.
Embolization means intentional occlusion of the feeding arteries of a tissue. For this, a catheter is placed into the feeding arteries and occluding materials such as small particles are injected. Once the arteries are occluded, the embolized tissue will have a reduction in blood supply, become smaller in size and may undergo partial or total necrosis (death). Thus, embolization may be used to stop bleeding anywhere in our body, to reduce the size of tumors or to kill tumors. For these purposes, it has been successfully used in medicine for about 50 years. Embolization has also been intensively used to treat uterine fibroids in the last 2 decades, and has rapidly become the treatment of choice in many types of this disease.
This web site has been prepared by Prof Saim Yilmaz, MD, who works at the Department of Interventional Radiology, Akdeniz University Medical Faculty, Antalya-Turkey. Its purpose is to provide objective information about the current therapeutic options for uterine fibroids with special emphasis on recent nonsurgical treatments including embolization.
Why uterine fibroid embolization (UFE)?